02 December 2008
GSK and Theravance announce positive phase 2b results for LABA, `444 in the Horizon Asthma Development programme
Chris Viehbacher, former President, North American Pharmaceuticals, gave a presentation at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference on 12 June in California.
We aim to create the best product pipeline in the industry for the benefit of patients, consumers and society.
Our R&D organisation measures productivity by the number and innovation of the products it creates, and also by the commercial value of the products.
Find out more about our pipeline